Heart Test Laboratories files 8-K/A to clarify reverse stock split and warrant adjustments

HeartSciences Inc.

Heart Test Laboratories filed Amendment No. 1 to Form 8-K to clarify details of its 1-for-100 reverse stock split.
The reverse stock split affects both common stock and warrants, with split-adjusted trading expected at market open on May 17, 2024.
The exercise price of public warrants will be proportionately increased to $425.00 per share post-split.
The CUSIP for common stock changes to 42254E302; trading symbols HSCS and HSCSW remain unchanged.
Equitable adjustments to outstanding warrants ensure every 100 pre-split shares become 1 post-split share upon exercise.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.